HomeBIOTECHNOLOGY

BIOTECHNOLOGY

XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure Using PASylation® Technology

Brian Johnson, Antlia Bioscience’s CEO commented, "chronic heart failure is a significantly unaddressed medical condition and a major public health concern. XL-protein's PASylation® technology will allow us to safely and effectively translate our peptide into a meaningful therapeutic option for patients with chronic heart failure.

OpenEye Scientific Reports: Gigadocking™ in Orion™ Molecular Design Platform Rapidly Identifies Novel Chemical Entities for GPCR Targets

OpenEye Scientific notes to quickly identify novel active compounds for known GPCR targets in Orion, the Beacon Discovery team used structure-based virtual screening through OpenEye's Gigadocking functionality—which performs massively parallel molecular docking through tens of thousands of CPUs at Amazon Web Service—and ligand-based virtual screening through FastROCS to rapidly screen the Enamine REAL collection of 2.5Bn commercially available molecules.

Summit Biolabs, Colorado Center for Personalized Medicine to Develop Saliva Tests for COVID, Head & Neck Cancer

CCPM holds one of the largest research biobanks in the United States with clinical data from more than 8.7 million de-identified patient records and plans to integrate the data with personalized genomic information.

ADEXUSDx® COVID-19 Antibody Test Independent Study Demonstrates 100% Specificity and 94.3% Sensitivity That Meets the Requirements for Clinical Use

October 12, 2020 ADEXUSDx® COVID-19 antibody test update: Now Diagnostics announced that an independent validation study of the ADEXUSDx® COVID-19 antibody test conducted by the...

CellAssist Provids Imaging, Analytics, and Documentation for Reproducible Cell Culture: Thrive Biosciences Launches

The CellAssist solves cell culture problems widely experienced by researchers and laboratory managers, including inconsistent and partial imaging of plates of cells, a lack of objective metrics, and incomplete documentation.

Natera Reports: Panorama® NIPT Receives Average Risk Coverage for an Additional 24 Million Lives

The expanded coverage follows the recent joint guideline released by the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine that supported offering aneuploidy screening options, including NIPT, to all patients, regardless of maternal age or baseline risk.

Medela Reports Their Portable Medical Surgical and Airway Suction Devices Offers a Safer Alternative to Piped Vaccum Systems

Medela notes they have been used in Europe and worldwide. The company’s portable medical suction machines are designed to provide crucial suction and fluid removal during respiratory treatment provided with ventilators.

EKF Diagnostics: PrimeStore® MTM Novel Viral Transport Media Successfully Evaluated by Public Health England for SARS-CoV-2 Inactivation

EKF Diagnostics notes the PHE study [1] evaluated numerous commercially available reagents and laboratory formulations commonly used for viral inactivation protocols by public health agencies and research laboratories globally.

Swift Biosciences and BillionToOne Partner Together for Commercialization and Manufacturing of EUA Approved COVID-19 Test

Swift Biosciences notes: The BillionToOne COVID-19 test uses different sets of instruments and chemicals from existing COVID-19 tests, enabling labs to unlock a new set of unused capacity.